Pfizer (NYSE:PFE) - Page 2

buy sell

Top Analyst Upgrades and Downgrades: Alcoa, GoPro, MetLife, Netflix, SUPERVALU, Disney, Williams, Yelp and Many More

Stocks were up marginally after looking for direction for most of Thursday's early bird indications, but this is after another big sell-off on Wednesday. The bears are getting bolder, and ...
Read Full Story »
Dow

The DJIA Bullish Case of 19,700 in 2016: Apple, Boeing, IBM, Nike, Pfizer, Goldman Sachs and More

A bull market interrupted is how many investors likely feel at the start of 2016 after the Dow Jones Industrial Average (DJIA) fell by 2.2% in 2015. Then the worst start ...
Read Full Story »
Medicine pills

Major Pharma Short Sellers Increase Bets

The short interest data have been released for the December 31 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Mine

The 6 Most Shorted NYSE Stocks: Pfizer and Freeport-McMoRan on the Rise

General Electric saw its short interest drop sharply between the December 15 and December 31 settlement dates for the second period in a row. Meanwhile, among the other most shorted ...
Read Full Story »
buy now

Merrill Lynch Has 4 Safe Dividend-Paying Mega-Cap Pharmaceutical Stocks to Buy

This week has been brutal for investors as the markets retraced the lion's share of the gains that came off the bottom of the late summer, early fall correction. However, ...
Read Full Story »
Prescription drugs

The 2016 Bullish and Bearish Case for Pfizer, Merck, Johnson & Johnson

Now that 2015 has ended, 24/7 Wall St. wanted to see what the strategists and analysts on Wall Street expect for the stock market in 2016. It turns out the ...
Read Full Story »
Dog

Meet the Full 2016 Dogs of the Dow for Massive Dividends

At the end of every year, investors look for opportunities and safe harbors in the year ahead. Now that 2015 has turned into 2016, investors who love dividends may want ...
Read Full Story »
Prescription drugs

Merrill Lynch Has 4 Large Cap Pharmaceutical Dividend Stocks for 2016

No matter whom the pundit is on Wall Street, the expectations for next year are not overly bullish. While few see massive declines, the big run on the S&P 500 ...
Read Full Story »
Medicine pills

Major Pharma Short Interest Takes Another Giant Leap Forward

The short interest data have been released for the December 15 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Quotes

The 6 Most Shorted NYSE Stocks: Short Sellers Still Fleeing GE

General Electric saw its short interest drop sharply again between the November 30 and December 15 settlement dates. GE was the only one among the most shorted stocks trading on ...
Read Full Story »
Large cap stocks

The 4 Stocks That Buoyed the DJIA on Thursday

December 24, 2015: Markets opened mixed on Thursday after thin trading and little movement in both Europe and Asia. The report on U.S. jobless claims was better than expected, but ...
Read Full Story »
2016 road ahead

Top-Yielding Jefferies Franchise List Stocks to Buy for 2016

With very little trading time left in what has been a disappointing 2015, many investors are trying to sort out the landscape for 2016. One thing is for sure, despite ...
Read Full Story »
thinkstockphotos-522646895

The 4 Stocks That Lifted the Dow on Monday

December 21, 2015: Markets opened higher on Monday following a changing of the guard at the top of Spain's government and new hope for another dose of government stimulus in ...
Read Full Story »
Dog

Dividends Galore: Meet the Preliminary 2016 Dogs of the Dow

At the end of every year, myriad strategies are announced for the coming year. With investors continuing to love dividends, one strategy that is reviewed every year is the so-called ...
Read Full Story »
ThinkstockPhotos-486788030

How Amgen’s Larger-Than-Expected Dividend Hike Stacks Up to Peers

Amgen Inc. (NASDAQ: AMGN) is getting aggressive enough on its dividend payout that you might think the biotech giant is now just a Big Pharma stock. The reality is that ...
Read Full Story »